Skip to main content
Smart Investors Daily
XT

AMEX · XTNT

Xtant Medical Holdings, Inc.

Healthcare · Medical - Devices

$0.34

Up+$0.01 (+1.75%)

Updated Sep 11, 2026, 12:27 PM

SID Score

2.8/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
97.85M
P/E ratio
-21.38
Dividend yield
0.00%
52-week range
$0.27 – $0.71
Volume
376.39K
Avg. volume
257.75K

Price performance

XTNT price history

1M range · 20 trading sessions · Daily adjusted prices

XTNT closed at $0.34 after 20 trading sessions, up 10.22% for the selected period.

Last close
$0.34
Period change
+10.22%
Period low
$0.31
Period high
$0.41
Daily close
View OHLC price history
XTNT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 10, 2026$0.3352$0.3583$0.32$0.3439376.39K
Sep 9, 2026$0.3905$0.3905$0.3369$0.338455.6K
Sep 8, 2026$0.40$0.4081$0.373$0.3801521.23K
Sep 4, 2026$0.3941$0.4035$0.3701$0.375380.26K
Sep 3, 2026$0.40$0.4199$0.38$0.3956642.86K
Sep 2, 2026$0.391$0.4364$0.3764$0.4098.9M
Sep 1, 2026$0.372$0.4098$0.3563$0.368767.7K
Aug 31, 2026$0.362$0.4199$0.346$0.3922.69M
Aug 28, 2026$0.3452$0.4861$0.3397$0.38477.61M
Aug 27, 2026$0.32$0.3441$0.32$0.335.13M
Aug 26, 2026$0.3209$0.3297$0.312$0.32150.27K
Aug 25, 2026$0.315$0.3282$0.312$0.319986.88K
Aug 24, 2026$0.33$0.33$0.315$0.322862.22K
Aug 21, 2026$0.34$0.34$0.32$0.3249143.97K
Aug 20, 2026$0.3398$0.3398$0.33$0.333348.5K
Aug 19, 2026$0.33$0.35$0.33$0.3301161.07K
Aug 18, 2026$0.33$0.3675$0.33$0.3315184.97K
Aug 17, 2026$0.31$0.433$0.31$0.33152.16M
Aug 14, 2026$0.30$0.3159$0.30$0.30533.24K
Aug 13, 2026$0.3005$0.3171$0.30$0.312151.86K

Latest XTNT news

The latest Smart Investors Daily articles mentioning XTNT.

XTNT research

Overview

Company profile and research snapshot.

Company profile

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$1.50
Implied upside
Analysts
XTNT recent ratings
DateFirmRatingTarget
Sep 2, 2026LUCID CAPITAL MARKETSBuy
May 13, 2026BTIGBuy
Mar 31, 2026BTIGBuy
Nov 11, 2025BTIGBuy
May 16, 2024BTIGBuy
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.